Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

38 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Not Yet Recruiting

Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT)

NCT07247786

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital General Universitario De Elche Elche, Alicante, Spain
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Quiron Dexeus Barcelona, Spain
View all 20 locations
View Trial Details
Completed

Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)

NCT04776447

Conditions
Bronchial Neoplasms, Carcinoma Bronchiogenic Stage III, Carcinoma, Bronchogenic, +10 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital General Universitario de Elche Elche, Alicante, Spain
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
View all 22 locations
View Trial Details
Completed

Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies

NCT05054725

Conditions
Bronchial Diseases, Bronchial Neoplasms, Carcinoma, +23 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • BRCR Medical Center Inc. Plantation, Florida, United States
  • Cancer Specialists of North Florida Saint Augustine, Florida, United States
  • GenHarp Clinical Solutions Evergreen Park, Illinois, United States
View all 60 locations
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Completed

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

NCT04774952

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +63 more
Locations
  • UC Irvine - Chao Family Comprehensive Cancer Center Irvine, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC

NCT03989115

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +61 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • UC Irvine - Chao Family Comprehensive Cancer Center Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
View all 24 locations
View Trial Details

Related conditions